CVRdatabase
Menu

2care4 Generics ApS

Private limited companyCVR 36960566Esbjerg VActive

2care4 Generics ApS is a private limited company, based in Esbjerg V, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2015. Net profit fell 35% from 2024 to 2025, ending at DKK 11.2m. With 32 employees, the company is about 4 times larger than the industry median. Equity fell to DKK 49.9m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 52.4m−9.9% vs. 2024
Net profitDKK 11.2m−34.8% vs. 2024
EquityDKK 49.9m−36.6% vs. 2024
Employees32latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 10% (2024 → 2025), to DKK 52.4m.
  • Net profit fell 35% (2024 → 2025), to DKK 11.2m.
  • Equity fell 37% (2024 → 2025), to DKK 49.9m.

Employees

  • 1 more employees than a year earlier: 32 (07/2026) against 31 (07/2025).

Management and owners, last 24 months

  • New in management: Ulrik Kronborg Markussen (director, 01/10/2026), Erik Sandberg (chair of the board, 01/10/2026) and Thomas Hørslev Hedegaard (ceo, 01/10/2026) (+1).
  • Stepped down: Henrik Bisgaard Jensen (board member, 16/12/2025), Ulrik Ernst Rasmussen (ceo, 24/03/2026) and Thomas Hjarsbæk Rasmussen (director, 01/12/2025) (+1).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 20mDKK 40mDKK 60mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for 2care4 Generics ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit32,85255,86375,69173,41458,19052,415−9.9%
Operating profit (EBIT)19,18236,16044,64941,16022,05615,951−27.7%
Profit before tax19,25536,25644,27240,48222,00514,315−34.9%
Net profit15,71529,08334,59831,56417,19311,207−34.8%
Total assets72,433127,774170,991170,370129,738115,193−11.2%
Equity15,54944,63274,23086,54478,73749,944−36.6%
Liabilities49,63674,97488,09875,15640,87851,842+26.8%
Cash and cash equivalents1,2861,97416,8974382,1250−100%
Average number of employees1215–232829+3.6%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70mDKK 80m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Equity fell sharply

    Equity fell 37% from 2024 to 2025 (DKK 78.7m to DKK 49.9m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for 2care4 Generics ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202506/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202423/04/2025The companyPDFXBRL
202301/01/2023 – 31/12/202330/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202227/04/2023The companyPDFXBRL
202101/01/2021 – 31/12/202124/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202002/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152025303508/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 52.4mNo. 51 of 232
Better than 78% of the companies in the industry
EquityDKK 49.9mNo. 44 of 232
Better than 81% of the companies in the industry
Number of employees32No. 56 of 232
Better than 76% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 400of 9,892
Better than 96%
No. 706of 9,922
Better than 93%
Same industry and 20–49 employees47 companies in the comparison
No. 18of 47
Better than 63%
No. 13of 47
Better than 74%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 653of 33,588
Better than 98%
No. 1,212of 33,687
Better than 96%
All companies of type ApS66,508 companies in the comparison
No. 674of 66,379
Better than 99%
No. 2,100of 66,505
Better than 97%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. 2care4 Generics ApSDKK 52.4m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. 2care4 Generics ApSDKK 11.2m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. 2care4 Generics ApSDKK 49.9m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. 2care4 Generics ApS32
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
2care4 Generics ApS

Management

4 active registrations

Executive management

Executive management at 2care4 Generics ApS
NameRoleAppointed
Ulrik Kronborg MarkussenDirector01/10/2026
Thomas Hørslev HedegaardCEO01/10/2026

Board of directors

Board of directors at 2care4 Generics ApS
NameRoleAppointed
Toke VærndalBoard member29/08/2016
Erik SandbergChair of the board01/10/2026
Founders
2care4 Group ApS
Former management (9)
Former management at 2care4 Generics ApS
NameRoleAppointedResigned
Henrik Fomsgaard-KnudsenCEO10/07/201512/02/2018
Henrik Fomsgaard-KnudsenBoard member29/08/201612/02/2018
Henrik Bisgaard JensenBoard member29/08/201616/12/2025
Toke VærndalCEO12/02/201801/05/2019
Torben BørstingDirector12/02/201806/09/2019
Torben BørstingBoard member12/02/201801/05/2019
Ulrik Ernst RasmussenCEO01/05/201924/03/2026
Thomas Hjarsbæk RasmussenDirector25/04/202401/12/2025
Erik SandbergCEO24/03/202601/10/2026

Signing rule: Selskabet tegnes af den samlede bestyrelse i forening eller af et bestyrelsesmedlem i forening med en direktør.

Address and production units

2 active production units

Stenhuggervej 12
6710 Esbjerg V

Esbjerg Municipality · Postcode 6710

Other companies at the address (3)

Production units
Production unitAddressEmployeesP number
2care4 Generics ApSStenhuggervej 12, 6710 Esbjerg V351020565507
2care4 Generics ApSEdisonsvej 2, 5000 Odense C–1029709013

Purpose

Selskabets formål er at udvikle, importere, producere, forhandle og eksportere lægemidler samt anden dermed i naturlig forbindelse stående virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

31 registered events
20267 changesmanagement 6 · accounts 1
  • Thomas Hørslev Hedegaard appointed ceo
  • Erik Sandberg appointed chair of the board
  • Ulrik Kronborg Markussen appointed director
  • Erik Sandberg stepped down as ceo
  • Annual report for 2025 published
  • Erik Sandberg appointed ceo
  • Ulrik Ernst Rasmussen stepped down as ceo
20253 changesmanagement 2 · accounts 1
  • Henrik Bisgaard Jensen stepped down as board member
  • Thomas Hjarsbæk Rasmussen stepped down as director
  • Annual report for 2024 published
20242 changesaccounts 1 · management 1
  • Annual report for 2023 published
  • Thomas Hjarsbæk Rasmussen appointed director
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20195 changesmanagement 4 · address 1
  • Torben Børsting stepped down as director
  • Moved to Stenhuggervej 12, 6710 Esbjerg V
  • Ulrik Ernst Rasmussen appointed ceo
  • Toke Værndal stepped down as ceo
  • Torben Børsting stepped down as board member
20185 changesmanagement 5
  • Toke Værndal appointed ceo
  • Torben Børsting appointed board member
  • Torben Børsting appointed director
  • Henrik Fomsgaard-Knudsen stepped down as board member
  • Henrik Fomsgaard-Knudsen stepped down as ceo
20163 changesmanagement 3
  • Toke Værndal appointed board member
  • Henrik Fomsgaard-Knudsen appointed board member
  • Henrik Bisgaard Jensen appointed board member
20153 changesfounded 1 · management 1 · ownership 1
  • Registered as 2care4 Generics ApS
  • Henrik Fomsgaard-Knudsen appointed ceo
  • 2care4 Group ApS registered as owner (100%)

Related companies

Same industry in Esbjerg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction